The cost-effectiveness of lifesaving interventions in Sweden

被引:0
|
作者
Center for Risk Research, Stockholm School of Economics, Box 6501, 113 83 Stockholm, Sweden [1 ]
机构
来源
RISK ANAL. | / 4卷 / 467-478期
关键词
Cost effectiveness - Statistical methods;
D O I
暂无
中图分类号
学科分类号
摘要
In this article, we discuss under what conditions an estimated cost per statistical life saved can be interpreted as an implied lifevalue. Furthermore, we state optimality conditions with respect to variation in implied lifevalues. The cost-effectiveness, together with references, are presented for 165 lifesaving interventions in Sweden. The cost-effectiveness of interventions has been found in publicly available analyses, or in some cases been calculated by us. Several of these interventions produce net savings for society. The most expensive interventions cost several hundred million SEK, or more, per life saved. To improve the comparability of the interventions, certain criteria have been used to standardize the estimates. Still, dissimilarities in the calculation of implied life values remain and the quality of the original data is in some cases uncertain. Despite this and the fact that the interventions are not a representative sample, it is nevertheless possible to conclude that implied life values vary greatly both within and between different sectors of the Swedish society, much in the same manner as in current U.S. analyses.
引用
收藏
相关论文
共 50 条
  • [21] Obesity Cost-Effectiveness of bariatric Interventions
    Dickmann, Ines
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2014, 19 (04):
  • [22] The cost-effectiveness of public health interventions
    Owen, Lesley
    Morgan, Antony
    Fischer, Alastair
    Ellis, Simon
    Hoy, Andrew
    Kelly, Michael P.
    JOURNAL OF PUBLIC HEALTH, 2012, 34 (01) : 37 - 45
  • [23] Cost-effectiveness analysis of radiological interventions
    Golder, W
    Borchert, M
    Leroux, E
    Wolf, KJ
    EUROPEAN RADIOLOGY, 2000, 10 (Suppl 3) : S435 - S437
  • [24] Cost-effectiveness of treatment with etanercept for psoriasis in Sweden
    Knight, Christopher
    Mauskopf, Josephine
    Ekelund, Mats
    Singh, Amitabh
    Yang, Shiyi
    Boggs, Robert
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2012, 13 (02): : 145 - 156
  • [25] Cost-effectiveness of influenza vaccination of elderly in Sweden
    Wolff, Ellen
    Larsson, S.
    Roth, A.
    Bastami, S.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2016, 26 : 28 - 28
  • [26] Cost-effectiveness of simple insulin infusion: Sweden
    Henriksen, O.
    Dall, M.
    Warner, J.
    Parkin, C.
    DIABETOLOGIA, 2015, 58 : S483 - S483
  • [27] Cost-effectiveness of pneumococcal vaccination for elderly in Sweden
    Wolff, Ellen
    Storsaeter, Jann
    Ortqvist, Ake
    Naucler, Pontus
    Larsson, Sofie
    Lepp, Tiia
    Roth, Adam
    VACCINE, 2020, 38 (32) : 4988 - 4995
  • [28] The cost-effectiveness of oral triptan therapy in Sweden
    Ramsberg, J.
    Henriksson, M.
    CEPHALALGIA, 2007, 27 (01) : 54 - 62
  • [29] COST-EFFECTIVENESS OF COMPLYING WITH TREATMENT GUIDELINES IN SWEDEN
    Jonsson, E.
    Hansson-Hedblom, A.
    Ljunggren, O.
    Akesson, K.
    Spangeus, A.
    Borgstrom, F.
    Kanis, J. A.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S440 - S440
  • [30] Cost-effectiveness of treatment with etanercept for psoriasis in Sweden
    Christopher Knight
    Josephine Mauskopf
    Mats Ekelund
    Amitabh Singh
    Shiyi Yang
    Robert Boggs
    The European Journal of Health Economics, 2012, 13 : 145 - 156